Neuropsychological and Differential Diagnostic Features in Patients with Acquired Non-Wilsonian Degeneration on the Background of Liver Cirrhosis
DOI:
https://doi.org/10.61788/njn.v2i22.04Keywords:
hepatic cirrhosis, liver failure, Parkinsonism, acquired non-Wilsonian hepatocerebral degenerationAbstract
Acquired non-Wilsonian hepatocerebral degeneration (ANHD) is a rare pathology that develops against the background of hepatic cirrhosis, for this reason, many aspects of this disease, including the nature of neuropsychological disorders, which has a diverse clinical picture are not well understood. The aim of this study is to describe the neuropsychological symptoms in patients with ANHD associated with hepatic cirrhosis.
References
1. Aarsland D, Bronnick K, Ehrt U, De Deyn PP, Tekin S, Emre M et al. Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress // J Neurol Neurosurg Psychiatry, 2007, vol. 78 (pg.36-42)
2. Binit Sureka, Kalpana Bansal, Yashwant Patidar, S. Rajesh, Amar Mukund, Ankur Arora. Neurologic Manifestations of Chronic Liver Disease and Liver Cirrhosis // Current Problems in Diagnostic Radiology, Volume 44, Issue 5,2015,Pages 449-461.
3. Burkhard PR, Delavelle J, Du Pasquier R, Spahr L. Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration // Arch Neurol 2003;60:521-528.
4. Butterworth RF. Metal toxity, liver disease and neurodegeneration // Neurotox Res 2010;18:100-105
5. Fénelon G, Mahieux F, Huon R, Ziégler M. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors // Brain, 2000, vol. 123 (pg. 733-45)
6. Ferrara J, Jankovic J. Acquired hepatocerebral degeneration // J Neur ol 2009;256:320–32.
7. Hilker R, Thomas AV, Klein JC, Weisenbach S, Kalbe E, Burghaus L, et al. Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways // Neurology, 2005 , vol. 65 (pg. 1716 -22)
8. Karin Weissenborn, Jochen C. Ennen, Hans Schomerus, Norbert RuÈckert, Hartmut Hecker. Neuropsychological characterization of hepatic encephalopathy // Journal of hepatology, vol.34, 2001, p.768-773.
9. Klos KJ, Ahlskog JE, Josephs KA, Fealey RD, Cowl CT, Kumar N. Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging // Arch Neurology 2005;62:1385-1390.
10. Klos KJ, Ahlskog J E, Kumar N, et al. Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity // Neurology 2006; 67:1984-1989.
11. Manford M, Andermann F. Complex visual hallucinations. Clinical and neurobiological insights // Brain, 1998, vol.121 (pg. 1819-40).
12. Oishi N, Udaka F, Kameyama M, Sawamoto N, Hashikawa K, Fukuyama H. Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations // Neurology, 2005, vol.65 (pg. 1708-15).
13. Sherlock S., Summerskill W.H.J., White L.P., Phear E.A. Portal-systemic encephalopathy. Neurological complications of liver disease // Lancet. 1954; 2: 453-457
14. Stracciari A, Guarino M, Pazzaglia P , et al. Acquired hepatocerebral degeneration: full recovery after liver transplantation // J Neurol Neurosurg Psychiatry 2001;70:136–7.
15. Gleason A, Hayhow B, Walterfang M, Evans A, Mocellin R, Gates P, Velakoulis D. Neuropsychiatric symptoms as the presenting feature of acquired hepatocerebral degeneration // Aust N Z J Psychiatry. 2014 Oct;48(10):959-60.
16. Manganelli F, Vitale C, Santangelo G, Pisciotta C, et al. Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease // Brain, Volume 132, Issue 9, September 2009, Pages 2350–2355.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 National Association of Neurologists
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
